Browsing by Author "June Fabian"
Now showing 1 - 20 of 24
Results Per Page
Sort Options
Item Adult and Paediatric Liver TransplantationWits Transplant Data 2020Carolyn Bouter; Russell Britz; Bernd Strobele; Sharan Rambarran; F Van Der Schyff; Lliam Brannigan; Despina Demopoulos; Marisa Beretta; Sarah Berkenfeld; Dinen Parbhoo; Bilal Bobat; Adam Mahomed; M Reynders; Heather Maher; P Gaylard; Harriet Etheredge; Jean Botha; June FabianItem The African Liver Tissue Biorepository Consortium Capacitating PopulationAppropriate Drug Metabolism Pharmacokinetics and Pharmacogenetics Research in Drug Discovery and Development(AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS) Collen Masimirembwa; Michele Ramsay; J Botha; E Ellis; Harriet Etheredge; Tracey Hurrell; C Kanji; Heather Maher; Busisiwe Mthembu; Sharan Rambarran; F van der Schyff; Natalie Smyth; Bernd Strobele; E et al; Jerome Loveland; June FabianItem Blood pressure increases are associated with weight gain and not antiretroviral regimen or kidney function a secondary analysis from the ADVANCE trial in South Africa(INT AIDS SOCIETY) Jennifer Manne-Goehler; June Fabian; Simiso Sokhela; Godspower Akpomiemie; N Rahim; Samanta Lalla-Edward; Alana Brennan; M Siedner; A Hill; Willem VenterItem Communication in healthcare Global challenges in the 21st CenturyHarriet Etheredge; June FabianItem Coronavirus Host Genomics Study: South Africa (COVIGen-SA)(2022-10-06) Andrew K. May; Heather Seymour; Harriet Etheredge; Heather Maher; Marta C. Nunes; ShabirA.Madhi; SimisoM. Sokhela; W. D. FrancoisVenter; Neil Martinson; Firdaus Nabeemeeah; Cheryl Cohen; Jocelyn Moyes; Sibongile Walaza; Stefano Tempia; Jackie Kleynhans; Anne von Gottberg; Jeremy Nel; Halima Dawood; Ebrahim Variava; Stephen Tollman; Kathleen Kahn; KobusHerbst; EmilyB.Wong; CarolineT.Tiemessen; Alex van Blydenstein; Lyle Murray; Michelle Venter; June Fabian; Miche´le RamsayHowever, continental Africans are yet to be adequately represented in such studies despite the importance of genetic factors in understanding Africa’s response to the pandemic. We describe the development of a research resource for coronavirus host genomics studies in South Africa known as COVIGen-SA—a multicollaborator strategic partnership designed to provide harmonised demographic, clinical, and genetic information specific to Black South Africans with COVID-19. Over 2,000 participants have been recruited to date. Preliminary results on 1,354 SARS-CoV-2 positive participants from four participating studies showed that 64.7% were female, 333 had severe disease, and 329 were people living with HIV. *rough this resource, we aim to provide insights into host genetic factors relevant to African-ancestry populations, using both genome-wide association testing and targeted sequencing of important genomic loci. *is project will promote and enhance partnerships, build skills, and develop resources needed to address the COVID-19 burden and associated risk factors in South African communities.Item Corrigendum Predicting Colorectal Cancer Recurrence and Patient Survival Using Supervised Machine Learning Approach A South African PopulationBased Study Frontiers in Public Health 2021 9 694306 103389fpubh2021694306Okechinyere Achilonu; June Fabian; Brandon Bebington; Elvira Singh; Gideon Nimako; M. J. C. Eijkemans; Eustasius MusengeItem Estimating population level 24-h sodium excretion using spot urine samples in older adults in rural South Africa(2023-02-01) Jacques D. Du Toita; David Kapaonb; Nigel J. Crowtherc; Shafika Abrahams-Gessele; June Fabian; Chodziwadziwa W. Kabudula; Alisha N. Wade; Stephen Tollman; Thomas A. GazianoBackground: South Africa has introduced regulations to reduce sodium in processed foods. Assessing salt consumption with 24-h urine collection is logistically challenging and expensive. We assess the accuracy of using spot urine samples to estimate 24-h urine sodium (24hrUNa) excretion at the population level in a cohort of older adults in rural South Africa. Methods: 24hrUNa excretion was measured and compared to that estimated from matched spot urine samples in 399 individuals, aged 40–75 years, from rural Mpumalanga, South Africa.We used the Tanaka, Kawasaki, International Study of Sodium, Potassium, and Blood Pressure (INTERSALT), and Population Mean Volume (PMV) method to predict 24hrUNa at the individual and population level. Results: The population median 24hrUNa excretion from our samples collected in 2017 was 2.6 g (interquartile range: 1.53–4.21) equal to an average daily salt intake of 6.6 g, whereas 65.4% of participants had a salt excretion above the WHO recommended 5 g/day. Estimated population median 24hrUNa derived from the INTERSALT, both with and without potassium, showed a nonsignificant difference of 0.25 g (P = 0.59) and 0.21 g (P = 0.67), respectively. In contrast, the Tanaka, Kawasaki, and PMV formulas were markedly higher than the measured 24hrUNa, with a median difference of 0.51 g (P = 0.004), 0.99 g (P = 0.00), and 1.05 g (P = 0.00) respectively. All formulas however performed poorly when predicting an individual’s 24hrUNa, Conclusion: In this population, the INTERSALT formulas are a well suited and cost-effective alternative to 24-h urine collection for the evaluation of population median 24hrUNa excretion. This could play an important role for governments and public health agencies in evaluating local salt regulations and identifying at-risk populations.Item Forgotten but not gone in rural South Africa urinary schistosomiasis and implications for chronic kidney disease screening in endemic countriesA Craik; M Gondwe; Nokthula Mayindi; Shingirai Chipungu; B Khoza; Francesc Gomez-Olive Casas; Stephen Tollman; John Frean; L Tomlinson; June FabianItem Forgotten but not gone in rural South Africa: Urinary schistosomiasis and implications for chronic kidney disease screening in endemic countries(2023-02-10) Alison Craik; Mwawi Gondwe; Nokthula Mayindi; Shingirai Chipungu; Bongekile Khoza; Xavier Gómez-Olivé; Stephen Tollman; John Frean; Laurie A. Tomlinson; June FabianBackground: Urinary schistosomiasis caused by infection with Schistosoma haematobium (S. haematobium) remains endemic in Africa and is associated with haematuria and albuminuria/proteinuria. Kidney Disease Improving Global Outcomes clinical guidelines recommend evaluating proteinuria/albuminuria and glomerular filtration rate for chronic kidney disease (CKD) diagnosis. The guidelines are informed by population data outside of Africa but have been adopted in many African countries with little validation. Our study aimed to characterise the burden of urinary schistosomiasis in rural South Africa (SA) and evaluate its relationship with markers of kidney dysfunction with implications for CKD screening. Methods: In this population-based cohort study, we recruited 2021 adults aged 20 – 79 years in the Mpumalanga Province, SA. Sociodemographic data were recorded, urinalysis performed, and serum creatinine and urine albumin and creatinine measured. Kidney dysfunction was defined as an estimated glomerular filtration rate (eGFR) <60ml/min/1.73m2 and/or urine albumin-creatinine ratio >3.0mg/mmol. S. haematobium infection was determined by urine microscopy. Multivariable analyses were performed to determine relationships between S. haematobium and markers of kidney dysfunction. Results: Data were available for 1226 of 2021 participants. 717 (58.5%) were female and the median age was 35 years (IQR 27 – 47). Prevalence of kidney dysfunction and S. haematobium was 20.2% and 5.1% respectively. S. haematobium was strongly associated with kidney dysfunction (OR 8.66; 95% CI 4.10 – 18.3) and related to albuminuria alone (OR 8.69; 95% CI 4.11 – 18.8), with no evidence of an association with eGFR <90ml/min/1.73m2 (OR 0.43; 95% CI 0.05 – 3.59). Discussion: The strong association between urinary schistosomiasis and albuminuria requires careful consideration when screening for CKD. Screening for, and treatment of, schistosomiasis should be a routine part of initial work-up for CKD in S. haematobium endemic areas. Urinary schistosomiasis, a neglected tropical disease, remains a public health concern in the Mpumulanga province of SA.Item Forgotten but not gone in rural South Africa: Urinary schistosomiasis and implications for chronic kidney disease screening in endemic countries [version 1; peer review: awaiting peer review](2023-02-10) Alison Craik; Mwawi Gondwe; Nokthula Mayindi; Shingirai Chipungu; Bongekile Khoza; Xavier Gómez-Olivé; Stephen Tollman; John Frean; Laurie A. Tomlinson; June FabianBackground: Urinary schistosomiasis caused by infection with Schistosoma haematobium (S. haematobium) remains endemic in Africa and is associated with haematuria and albuminuria/proteinuria. Kidney Disease Improving Global Outcomes clinical guidelines recommend evaluating proteinuria/albuminuria and glomerular filtration rate for chronic kidney disease (CKD) diagnosis. The guidelines are informed by population data outside of Africa but have been adopted in many African countries with little validation. Our study aimed to characterise the burden of urinary schistosomiasis in rural South Africa (SA) and evaluate its relationship with markers of kidney dysfunction with implications for CKD screening. Methods: In this population-based cohort study, we recruited 2021 adults aged 20 – 79 years in the Mpumalanga Province, SA. Sociodemographic data were recorded, urinalysis performed, and serum creatinine and urine albumin and creatinine measured. Kidney dysfunction was defined as an estimated glomerular filtration rate (eGFR) <60ml/min/1.73m2 and/or urine albumin-creatinine ratio>3.0mg/mmol. S. haematobium infection was determined by urine microscopy. Multivariable analyses were performed to determine relationships between S. haematobium and markers of kidney dysfunction. Results: Data were available for 1226 of 2021 participants. 717 (58.5%) were female and the median age was 35 years (IQR 27 – 47). Prevalence of kidney dysfunction and S. haematobium was 20.2% and 5.1% respectively. S. haematobium was strongly associated with kidney dysfunction (OR 8.66; 95% CI 4.10 – 18.3) and related to albuminuria alone (OR 8.69; 95% CI 4.11 – 18.8), with no evidence of an association with eGFR <90ml/min/1.73m2 (OR 0.43; 95% CI 0.05 – 3.59). Discussion: The strong association between urinary schistosomiasis and albuminuria requires careful consideration when screening for CKD. Screening for, and treatment of, schistosomiasis should be a routine part of initial work-up for CKD in S. haematobium endemic areas. Urinary schistosomiasis, a neglected tropical disease, remains a public health concern in the Mpumulanga province of SA.Item Identifying the prevalence and correlates of multimorbidity in middle-aged men and women: a cross-sectional populationbased study in four African countries(2023-02-15) Lisa K Micklesfield; Richard Munthali; Godfred Agongo; Gershim Asiki; Palwende Boua; Solomon SR Choma; Nigel J Crowther; June Fabian; Francesc Xavier Gómez-Olivé; Chodziwadziwa Kabudula; Eric Maimela; Shukri F Mohamed; Engelbert A Nonterah; Frederick J Raal; Hermann Sorgho; Furahini D Tluway; Alisha N Wade; Shane A Norris; Michele RamsayObjectives To determine the prevalence of multimorbidity, to identify which chronic conditions cluster together and to identify factors associated with a greater risk for multimorbidity in sub-Saharan Africa (SSA). Design Cross-sectional, multicentre, population-based study. Setting Six urban and rural communities in four subSaharan African countries. Participants Men (n=4808) and women (n=5892) between the ages of 40 and 60 years from the AWI-Gen study. Measures Sociodemographic and anthropometric data, and multimorbidity as defined by the presence of two or more of the following conditions: HIV infection, cardiovascular disease, chronic kidney disease, asthma, diabetes, dyslipidaemia, hypertension. Results Multimorbidity prevalence was higher in women compared with men (47.2% vs 35%), and higher in South African men and women compared with their East and West African counterparts. The most common disease combination at all sites was dyslipidaemia and hypertension, with this combination being more prevalent in South African women than any single disease (25% vs 21.6%). Age and body mass index were associated with a higher risk of multimorbidity in men and women; however, lifestyle correlates such as smoking and physical activity were different between the sexes. Conclusions The high prevalence of multimorbidity in middle-aged adults in SSA is of concern, with women currently at higher risk. This prevalence is expected to increase in men, as well as in the East and West African region with the ongoing epidemiological transition. Identifying common disease clusters and correlates of multimorbidity is critical to providing effective interventions.Item A machine learning approach towards assessing consistency and reproducibility an application to graft survival across three kidney transplantation erasOkechinyere Achilonu; G Obaido; B Ogbuokiri; K Aruleba; Eustasius Musenge; June FabianItem Measurement of kidney function in Malawi, South Africa, and Uganda: a multicentre cohort study(2022) June Fabian; Robert Kalyesubula; Joseph Mkandawire; Christian Holm Hansen; Dorothea Nitsch; Eustasius Musenge; Wisdom P Nakanga; Josephine E Prynn; Gavin Dreyer; Tracy Snyman; Billy Ssebunnya; Michele Ramsay; Liam Smeeth; Stephen Tollman; Saraladevi Naicker; Amelia Crampin; Robert Newton; Jaya A George; Laurie TomlinsonBackground The burden of kidney disease in many African countries is unknown. Equations used to estimate kidney function from serum creatinine have limited regional validation. We sought to determine the most accurate way to measure kidney function and thus estimate the prevalence of impaired kidney function in African populations. Methods We measured serum creatinine, cystatin C, and glomerular filtration rate (GFR) using the slope-intercept method for iohexol plasma clearance (mGFR) in population cohorts from Malawi, Uganda, and South Africa. We compared performance of creatinine and cystatin C-based estimating equations to mGFR, modelled and validated a new creatinine-based equation, and developed a multiple imputation model trained on the mGFR sample using age, sex, and creatinine as the variables to predict the population prevalence of impaired kidney function in west, east, and southern Africa. Findings Of 3025 people who underwent measured GFR testing (Malawi n=1020, South Africa n=986, and Uganda n=1019), we analysed data for 2578 participants who had complete data and adequate quality measurements. Among 2578 included participants, creatinine-based equations overestimated kidney function compared with mGFR, worsened by use of ethnicity coefficients. The greatest bias occurred at low kidney function, such that the proportion with GFR of less than 60 mL/min per 1·73 m² either directly measured or estimated by cystatin C was more than double that estimated from creatinine. A new creatinine-based equation did not outperform existing equations, and no equation, including the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) 2021 race-neutral equation, estimated GFR within plus or minus 30% of mGFR for 75% or more of the participants. Using a model to impute kidney function based on mGFR, the estimated prevalence of impaired kidney function was more than two-times higher than creatinine-based estimates in populations across six countries in Africa. Interpretation Estimating GFR using serum creatinine substantially underestimates the individual and populationlevel burden of impaired kidney function in Africa with implications for understanding disease progression and complications, clinical care, and service provision. Scalable and affordable ways to accurately identify impaired kidney function in Africa are urgently needed.Item Needs must Living donor liver transplantation from an HIVpositive mother to her HIVnegative child in Johannesburg South AfricaHarriet Etheredge; June Fabian; Eleanor Duncan; Francesca Conradie; Caroline Tiemessen; Jean BothaItem Osteoporosis, Rather Than Sarcopenia, Is the Predominant Musculoskeletal Disease in a Rural South African Community Where Human Immunodeficiency Virus Prevalence Is High: A Cross-Sectional Study(2022-02) Celia L. Gregson; Tafadzwa Madanhire; Andrea Rehman; Rashida A. Ferrand; Anne R. Cappola; Steven Tollman; Tshepiso Mokoena; The ARK Consortium; Lisa K. Micklesfield; Alisha N. Wade; June FabianThe rollout of antiretroviral therapy globally has increased life expectancy across Southern Africa, where 20.6 million people now live with human immunodeficiency virus (HIV). We aimed to determine the prevalence of age-related osteoporosis and sarcopenia, and investigate the association between HIV, bone mineral density (BMD), muscle strength and lean mass, and gait speed. A cross-sectional community-based study of individuals aged 20–80 years in rural South Africa collected demographic and clinical data, including HIV status, grip strength, gait speed, body composition, and BMD. Sarcopenia was defined by the European Working Group on Sarcopenia in Older People 2 (EWGSOP2) guidelines, and osteoporosis as BMD T-score ≤ −2.5 (if age ≥50 years). The mean ± standard deviation (SD) age of 805 black South African participants was 44.6 ± 14.8 years, 547 (68.2%) were female; 34 (13.2%) were men, and 129 (23.6%) women had HIV, with 88% overall taking anti-retroviral therapy. A femoral neck T-score ≤ −2.5, seen in four of 95 (4.2%) men and 39 of 201 (19.4%) women age ≥50 years, was more common in women with than without HIV (13/35 [37.1%] versus 26/166 [15.7%]; p = 0.003). Although no participant had confirmed sarcopenia, probable sarcopenia affected more men than women (30/258 [11.6%] versus 24/547 [4.4%]; p = .001]. Although appendicular lean mass (ALM)/height2 index was lower in both men and women with HIV, there were no differences in grip strength, gait speed, or probable sarcopenia by HIV status. Older age, female sex, lower ALM/height2 index, slower gait speed, and HIV infection were all independently associated with lower femoral neck BMD. In conclusion, osteoporosis rather than sarcopenia is the common musculoskeletal disease of aging in rural South Africa; older women with HIV may experience greater bone losses than women without HIV. Findings raise concerns over future fracture risk in Southern Africa, where HIV clinics should consider routine bone health assessment, particularly in aging women.Item Patient perceptions of surgical training in the private sector in South Africa a single centre surveyDean Lutrin; Harriet Etheredge; June Fabian; Carolyn Bouter; Susan TagerItem Practising in a posttruth world Pandemic ethics can inform patient autonomy and clinical communicationLliam Brannigan; Harriet Etheredge; Aina Lundgren; June FabianItem Preoperative physical activity and functional performance levels are predictors of acute postoperative outcomes in a private south african colorectal cancer cohortMegan Whelan; Helena Van Aswegen; Ronel Roos; June Fabian; Brandon BebingtonItem Rare but fatal if missed intraoperative Takotsubo syndrome in adult liver transplantation lessons for anaesthesia and intensive care cliniciansTafadzwa Chitagu; Bilal Bobat; Ahmed Vachiat; June Fabian; Lliam Brannigan